Literature DB >> 15583183

Excess in the pharmaceutical industry.

Marcia Angell1.   

Abstract

Mesh：

Year:  2004        PMID： 15583183      PMCID： PMC534578          DOI： 10.1503/cmaj.1041594

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Separating continuing medical education from pharmaceutical marketing.

Authors:  A S Relman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

2.  Health spending rebound continues in 2002.

Authors:  Katharine Levit; Cynthia Smith; Cathy Cowan; Art Sensenig; Aaron Catlin
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Feb       Impact factor: 6.301
  2 in total
  9 in total

1.  Why U.S. health care expenditure and ranking on health care indicators are so different from Canada's.

Authors:  A H G M Spithoven
Journal:  Int J Health Care Finance Econ       Date:  2008-07-01

2.  Regulation of the pharmaceutical industry: promoting health or protecting wealth?

Authors:  Alan Maynard; Karen Bloor
Journal:  J R Soc Med       Date:  2015-04-28       Impact factor: 5.344

Review 3.  Genomic medicine: genetic variation and its impact on the future of health care.

Authors:  Huntington F Willard; Misha Angrist; Geoffrey S Ginsburg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

4.  Use of community forums to increase knowledge of HPV and cervical cancer in African American communities.

Authors:  Dede Kossiwa Teteh; Lenna Dawkins-Moultin; Chartay Robinson; Victor LaGroon; Stanley Hooker; Kenneth Alexander; Rick A Kittles
Journal:  J Community Health       Date:  2019-06

5.  The status of clinical trials: cause for concern.

Authors:  Robert B Nussenblatt; Curtis L Meinert
Journal:  J Transl Med       Date:  2010-07-07       Impact factor: 5.531

6.  Pharmaceutical marketing and the invention of the medical consumer.

Authors:  Kalman Applbaum
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

7.  Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States.

Authors:  Crystal Adams; Anwesa Chatterjee; Brittany M Harder; Liza Hayes Mathias
Journal:  SSM Popul Health       Date:  2018-04-12

Review 8.  Shifting emphasis from pharmacogenomics to theragnostics.

Authors:  Vural Ozdemir; Bryn Williams-Jones; Stephen J Glatt; Ming T Tsuang; James B Lohr; Christopher Reist
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

9.  Assessing the effectiveness of OTC Advertising on artificial tear drops from an experiential marketing perspective.

Authors:  Consuela-Mădălina Gheorghe; Victor Lorin Purcărea; Iuliana Raluca Gheorghe
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.